| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.004 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |